PHSC PLC
LSE:PHSC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (4.8), the stock would be worth GBX-9.29 (216% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -4.2 | GBX8 |
0%
|
| 3-Year Average | 4.8 | GBX-9.29 |
-216%
|
| 5-Year Average | 4.9 | GBX-9.33 |
-217%
|
| Industry Average | 0 | GBX-0.05 |
-101%
|
| Country Average | 0 | GBX-0.04 |
-100%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
PHSC PLC
LSE:PHSC
|
822.5k GBP | -4.2 | -3.7 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
98.3B USD | 14.1 | 55.4 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 7.8 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.9B USD | 0 | 12.3 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.4B EUR | 9.5 | 18.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.2B EUR | 9.1 | 23.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.6B USD | 12.1 | 22.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD | 12.2 | 25.4 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.1B EUR | 5.4 | 11.2 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.8B USD | -30.7 | -28.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 7.2 | 13.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 743.2 |
Other Multiples
PHSC PLC
Glance View
PHSC Plc operates through its subsidiaries, which provides a range of health, safety, hygiene, environmental and quality systems consultancy and training services to organizations across the United Kingdom. The company is headquartered in Aylesford, Kent. The company went IPO on 2005-07-04. The firm is a provider of health, safety, hygiene and environmental consultancy services and security solutions to the public and private sectors. The company specializes in occupational safety and health, environmental management, management systems and electronic security tagging and closed-circuit television (CCTV). The firm operates three divisions, namely Safety, Systems and Security. Its safety division include health and safety, food safety, legionella and occupational hygiene, statutory examination, and training. Its system division consists of training and consultancy. The security division include CCTV, security tagging (systems and consumables), foot fall counting / analysis, product protection, and security labels. The firm's subsidiaries include Personnel Health & Safety Consultants Ltd, RSA Environmental Health Ltd, QCS International Ltd, Inspection Services (UK) Ltd and Quality Leisure Management Ltd.
